Topic · page 14 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 521–560 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

Lupus Sci Med11 Nov 2025
Impact of glucocorticoid dose threshold in definition of lupus low disease activity state: a multinational observational cohort study
Cohort study
Clin Exp Rheumatol11 Nov 2025
Social support and depression status are risk factors of frailty in systemic lupus erythematosus patients: multicentre retrospective analysis using the Systemic Lupus Erythematosus International Collaborating Clinics-Frailty Index
Cross-sectional study
Rheumatology (Oxford)11 Nov 2025
Disease progression in patients with systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS)
Cohort study
Ann Rheum Dis11 Nov 2025
25-Hydroxyvitamin D levels are associated with mortality and cardiovascular events in systemic lupus erythematosus
Cohort study
Arthritis Care Res (Hoboken)11 Nov 2025
Centering Patient Voices in Lupus Pain: A Biopsychosocial Analysis of Reddit Narratives Using Large Language Models
Cross-sectional study
Arthritis Rheumatol11 Nov 2025
Differences in IgG Sialylation Distinguish Asymptomatic From Symptomatic Antinuclear Antibody–Positive Individuals
Mechanistic study
Lupus Sci Med10 Nov 2025
Cardiovascular magnetic resonance as an initial screening tool in individuals with SLE and chest pain
Cross-sectional study
Semin Arthritis Rheum10 Nov 2025
Distinct changes in nailfold capillaries are associated with the clinical and serological features of patients with systemic lupus erythematosus
Cross-sectional study
Lupus Sci Med10 Nov 2025
Real-world immune response to SARS-CoV-2 vaccination in Thai patients with systemic lupus erythematosus: a cross-sectional observational study
Cross-sectional study
Semin Arthritis Rheum8 Nov 2025
Recurrent thrombosis and hemorrhagic events in a large single-center primary antiphospholipid syndrome cohort: Results from APS-Rio cohort after nearly 1,000 patient-years of follow-up
Cohort study
Lupus Sci Med7 Nov 2025
Proteins upregulated in thrombotic antiphospholipid syndrome linked to platelet function in contrast with non-antiphospholipid-related thrombosis: insights from two systematic reviews
Meta-analysis
Rheumatology (Oxford)7 Nov 2025
Interstitial lung disease in SLE: a 30-year population study
Cohort study
Semin Arthritis Rheum6 Nov 2025
Circulating biomarkers and detection of pulmonary diseases in patients with systemic lupus erythematosus: A systematic review and meta-analysis of observational studies
Meta-analysis
Ann Rheum Dis6 Nov 2025
Low-dose belimumab reduced risk of flares in patients with systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial
Randomized controlled trial
Lupus6 Nov 2025
Frailty in systemic lupus erythematosus:A scoping review
Research article
Scand J Rheumatol5 Nov 2025
Progression of atherosclerotic plaques over 3 years in patients with systemic lupus erythematosus is inversely associated with continuous hydroxychloroquine treatment
Cohort study
Lupus Sci Med5 Nov 2025
Diagnostic implication of left atrial stiffness index in patients with SLE with left ventricular diastolic dysfunction
Diagnostic or prognostic study
Arthritis Rheumatol4 Nov 2025
2025 American College of Rheumatology ( ACR ) Guideline for the Treatment of Systemic Lupus Erythematosus
Guideline or statement
Scand J Rheumatol4 Nov 2025
Cancer risk in patients with systemic lupus erythematosus: a population-based cohort study in the Republic of Korea 2004–2021
Cohort study
Lupus Sci Med4 Nov 2025
Comparison of obinutuzumab and rituximab for treating neuropsychiatric lupus: a retrospective case-control study
Case-control study
Arthritis Care Res (Hoboken)3 Nov 2025
2025 American College of Rheumatology ( ACR ) Guideline for the Treatment of Systemic Lupus Erythematosus
Guideline or statement
Arthritis Care Res (Hoboken)3 Nov 2025
A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development
Cross-sectional study
Lupus3 Nov 2025
Risk factors associated with tuberculosis in systemic lupus erythematosus: A case-control study in Indonesia
Case-control study
Rheumatology (Oxford)3 Nov 2025
Imbalance between serum DNase-I protein levels and enzymatic activity in SLE: link with mitochondrial-DNA and low-density granulocytes
Cross-sectional study
J Rheumatol1 Nov 2025
Comorbidity Development and Mortality During 10 Years of Follow-up in a Danish Nationwide Cohort of 3178 Patients With Systemic Lupus Erythematosus
Cohort study
Lupus31 Oct 2025
Thrombocytopenia in systemic lupus erythematosus real-world insights from the nationwide RISE database
Cohort study
RMD Open31 Oct 2025
Poor health-related quality of life despite Lupus Low Disease Activity State or Definitions of Remission in systemic lupus erythematosus (SLE) remission in patients with SLE: results from a clinical trial setting
Secondary analysis
Lupus30 Oct 2025
A randomized controlled trial of a lifestyle intervention on wellbeing in patients with systemic lupus erythematosus: Results from “Living well with lupus”
Randomized controlled trial
Rheumatology (Oxford)30 Oct 2025
Comparable 12-month renal response outcomes with medium- vs high-dose starting prednisone in a real-world study of Lupus Nephritis
Cohort study
Arthritis Care Res (Hoboken)30 Oct 2025
Where, How, and How Much? A Multicenter Cohort Study of the Relationship Across Lupus Decision‐Aid Modality, Place of Administration, Interruption and Viewing Completeness, and Patient‐Reported Outcomes
Cohort study
Lupus Sci Med29 Oct 2025
Role of combination immunotherapy in restoring brain synergistic functional connectivity in patients with systemic lupus erythematosus without overt neuropsychiatric manifestations
Cross-sectional study
Lupus29 Oct 2025
Thirty-year trajectory of organ damage accrual and damage-free survival in Colombian patients with systemic lupus erythematosus: A registry-based retrospective follow-up study
Cohort study
Lupus Sci Med29 Oct 2025
Detection rate, demographic associations and clinical implications of anti-C1q antibody elevations across diverse disease states
Cohort study
Lupus Sci Med29 Oct 2025
Pharmacokinetics, effectiveness, tolerability and effect on quality of life of open-label tofacitinib for the treatment of moderately active mucocutaneous manifestations of SLE: results of a 76-week phase II study
Research article
Lupus29 Oct 2025
Safety and tolerability of combination rituximab and belimumab therapy in systemic lupus erythematosus: A systematic review
Meta-analysis
Clin Exp Rheumatol28 Oct 2025
Development of a machine learning-based nomogram for predicting atherosclerosis risk in patients with systemic lupus erythematosus
Diagnostic or prognostic study
Arthritis Res Ther27 Oct 2025
Effectiveness and safety of tacrolimus in systemic lupus erythematosus with various clinical manifestations: a retrospective real-world study
Cohort study
Lupus25 Oct 2025
Human papillomavirus vaccine uptake in ethnically diverse women living with systemic lupus erythematosus
Cross-sectional study
Lupus Sci Med23 Oct 2025
Corneal confocal microscopy: a novel biomarker of small fibre neuropathy in SLE
Cross-sectional study
Lupus Sci Med23 Oct 2025
Enpatoran, a first-in-class, selective, orally administered toll-like receptor 7/8 inhibitor, in systemic and cutaneous lupus erythematosus: results from a randomised, placebo-controlled phase Ib study
Randomized controlled trial

All 1,848 Briefs in ExploreShowing Briefs 521–560 of 1,848, newest first